These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12144536)

  • 21. Comparative analysis of cytokines released by bone marrow stromal cells from normal donors and B-cell chronic lymphocytic leukemic patients.
    Lagneaux L; Delforge A; Bron D; Bosmans E; Stryckmans P
    Leuk Lymphoma; 1995 Mar; 17(1-2):127-33. PubMed ID: 7773149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Frequency and functional characterization of exhausted CD8
    Taghiloo S; Allahmoradi E; Tehrani M; Hossein-Nataj H; Shekarriz R; Janbabaei G; Abediankenari S; Asgarian-Omran H
    Eur J Haematol; 2017 Jun; 98(6):622-631. PubMed ID: 28306177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for involvement of activated CD8+/HLA-DR+ cells in the pathogenesis of neutropenia in patients with B-cell chronic lymphocytic leukaemia.
    Katrinakis G; Kyriakou D; Alexandrakis M; Sakellariou D; Foudoulakis A; Eliopoulos GD
    Eur J Haematol; 1995 Jul; 55(1):33-41. PubMed ID: 7615048
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine expression in B-CLL in relation to disease progression and in vitro activation.
    Aguilar-Santelises M; Gigliotti D; Osorio LM; Santiago AD; Mellstedt H; Jondal M
    Med Oncol; 1999 Dec; 16(4):289-95. PubMed ID: 10618692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanded antigen-experienced CD160
    Bozorgmehr N; Okoye I; Oyegbami O; Xu L; Fontaine A; Cox-Kennett N; Larratt LM; Hnatiuk M; Fagarasanu A; Brandwein J; Peters AC; Elahi S
    J Immunother Cancer; 2021 Apr; 9(4):. PubMed ID: 33931471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of accessory cells in cytokine production by T cells in chronic B-cell lymphocytic leukemia.
    Decker T; Flohr T; Trautmann P; Aman MJ; Holter W; Majdic O; Huber C; Peschel C
    Blood; 1995 Aug; 86(3):1115-23. PubMed ID: 7620165
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD23 antigen regulation and signaling in chronic lymphocytic leukemia.
    Fournier S; Delespesse G; Rubio M; Biron G; Sarfati M
    J Clin Invest; 1992 Apr; 89(4):1312-21. PubMed ID: 1532590
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human T lymphocyte activation by pokeweed mitogen induces production of TNF-alpha and GM-CSF and helper signaling by IL-1 and IL-6 results in IL-2-dependent T cell growth.
    Wallays G; Ceuppens JL
    Eur Cytokine Netw; 1993; 4(4):269-77. PubMed ID: 8268417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spontaneous Immunity Against the Receptor Tyrosine Kinase ROR1 in Patients with Chronic Lymphocytic Leukemia.
    Hojjat-Farsangi M; Jeddi-Tehrani M; Daneshmanesh AH; Mozaffari F; Moshfegh A; Hansson L; Razavi SM; Sharifian RA; Rabbani H; Österborg A; Mellstedt H; Shokri F
    PLoS One; 2015; 10(11):e0142310. PubMed ID: 26562161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interleukin-2 enhances the production of tumor necrosis factor-alpha in activated B-type chronic lymphocytic leukemia (B-CLL) cells.
    Larsson LG; Carlsson M; Schena M; Lantz M; Caligaris-Cappio F; Nilsson K
    Leukemia; 1993 Feb; 7(2):226-34. PubMed ID: 8381194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of granulocyte-macrophage colony-stimulating factor by T cells is regulated by B7 and IL-1 beta.
    Kruger M; Van Gool S; Peng XH; Coorevits L; Casteels-Van Daele M; Ceuppens JL
    Immunology; 1996 May; 88(1):49-54. PubMed ID: 8707349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia.
    Jadidi-Niaragh F; Ghalamfarsa G; Memarian A; Asgarian-Omran H; Razavi SM; Sarrafnejad A; Shokri F
    Tumour Biol; 2013 Apr; 34(2):929-40. PubMed ID: 23269607
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro dendritic cell-induced T cell responses to B cell chronic lymphocytic leukaemia enhanced by IL-15 and dendritic cell-B-CLL electrofusion hybrids.
    Goddard RV; Prentice AG; Copplestone JA; Kaminski ER
    Clin Exp Immunol; 2003 Jan; 131(1):82-9. PubMed ID: 12519390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IFN-alpha stimulates proliferation and cytokine secretion of CD40-stimulated B cell chronic lymphocytic leukemia cells in vitro.
    Brass U; Tretter T; Schneller F; Schuler M; Huber C; Peschel C
    J Interferon Cytokine Res; 1999 Apr; 19(4):335-43. PubMed ID: 10334384
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Production of B-cell growth factor interleukin 2 and gamma interferon by peripheral blood lymphocytes from patients with chronic lymphocytic leukemia of B-cell type.
    Rossi JF; Commes T; Grenier J; Jourdan M; Chichehian B; Klein B
    Am J Hematol; 1988 Dec; 29(4):183-8. PubMed ID: 3142255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon alpha in combination with GM-CSF induces the differentiation of leukaemic antigen-presenting cells that have the capacity to stimulate a specific anti-leukaemic cytotoxic T-cell response from patients with chronic myeloid leukaemia.
    Chen X; Regn S; Raffegerst S; Kolb HJ; Roskrow M
    Br J Haematol; 2000 Nov; 111(2):596-607. PubMed ID: 11122108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Abnormal T-cell function in B-cell chronic lymphocytic leukaemia.
    Scrivener S; Goddard RV; Kaminski ER; Prentice AG
    Leuk Lymphoma; 2003 Mar; 44(3):383-9. PubMed ID: 12688308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. B-chronic lymphocytic leukemia cells exert an in vitro cytotoxicity mediated by tumor necrosis factor alpha.
    Rosati E; Sabatini R; Tabilio A; Di Ianni M; Bartoli A; Marconi P
    Leuk Res; 2005 Jul; 29(7):829-39. PubMed ID: 15927678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diminished production of interleukin-6 in chronic lymphocytic leukaemia (B-CLL) cells from patients at advanced stages of disease. Tampere CLL Group.
    Hulkkonen J; Vilpo J; Vilpo L; Hurme M
    Br J Haematol; 1998 Mar; 100(3):478-83. PubMed ID: 9504629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.